You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sclc

Showing 26 - 50 of 720
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

    Not yet recruiting
    • Relapsed Small Cell Lung Cancer
    • Irinotecan hydrochloride liposome Injection
    • Topotecan
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Nov 7, 2023

    Small-cell Lung Cancer Trial in New York (Carboplatin, Etoposide, Atezolizumab)

    Recruiting
    • Small-cell Lung Cancer
    • New York, New York
      Columbia University Irving Medical Center, Herbert Irving Compre
    Apr 7, 2022

    Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

    Active, not recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Haikou, Hainan, China
      Hainan General Hospital
    Jun 13, 2022

    Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

    Active, not recruiting
    • Small-cell Lung Cancer
    • Brain Metastases
    • Duarte, California
    • +5 more
    Oct 10, 2022

    Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

    Not yet recruiting
    • Lung Neoplasms
    • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
    • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
    • (no location specified)
    Jun 12, 2023

    Extensive Stage Small Cell Lung Carcinoma Trial in United States (Pembrolizumab, Laboratory Biomarker Analysis)

    Active, not recruiting
    Has Results
    • Extensive Stage Small Cell Lung Carcinoma
    • Pembrolizumab
    • Laboratory Biomarker Analysis
    • Chicago, Illinois
    • +4 more
    Jun 28, 2022

    Extensive Stage Small Cell Lung Cancer Trial in France ([177Lu]Lu-DOTA-TATE, Tislelizumab, [68Ga]Ga-DOTA-TATE)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Lille, France
    • +6 more
    Jan 23, 2023

    Outcomes ofBrazilian Cohort of Previously Untreated Extensive

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Observational study
    • (no location specified)
    Aug 24, 2023

    Extensive-stage Small-cell Lung Cancer Trial (Surufatinib Durvalizumab EP/EC)

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Surufatinib Durvalizumab EP/EC
    • (no location specified)
    Dec 20, 2022

    SCLC, NSCLC Trial (MILs™ in Combination with Pembrolizumab)

    Withdrawn
    • SCLC
    • NSCLC
    • MILs™ in Combination with Pembrolizumab
    • (no location specified)
    Oct 1, 2021

    SCLC,Extensive Stage Trial in Italy (Pembrolizumab/Olaparib)

    Not yet recruiting
    • SCLC,Extensive Stage
    • Meldola, Forlì Cesena, Italy
    • +9 more
    Nov 11, 2022

    Small Cell Lung Cancer (SCLC) Trial in Beijing (JK-1201I)

    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Dec 14, 2021

    Small Cell Lung Cancer (SCLC) Trial in New York (biological, drug, radiation)

    Terminated
    Has Results
    • Small Cell Lung Cancer (SCLC)
    • Pembrolizumab
    • +4 more
    • New York, New York
      Laura and Isaac Perlmutter Cancer Center at NYU Langone
    Oct 18, 2021

    SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

    Recruiting
    • SCLC
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation

    Not yet recruiting
    • Patients With Advanced Solid Tumor (Excluding NSCLC, SCLC, and Mesothelioma) With Results From a Multi-gene Next-generation Sequencing (NGS) Panel (>30 Genes)
    • Minimal documentation
    • Extended documentation
    • Mannheim, Baden-Württemberg, Germany
    • +1 more
    Jan 18, 2023

    Phase 1, NSCLC, SCLC Trial in United States (Oral MRT-2359)

    Recruiting
    • NSCLC
    • +6 more
    • Oral MRT-2359
    • Scottsdale, Arizona
    • +7 more
    Dec 20, 2022

    Small Cell Lung Cancer Extensive Stage Trial in Jinan, Tianjin, Zhengzhou (IN10018, Tislelizumab, Carboplatin)

    Not yet recruiting
    • Small Cell Lung Cancer Extensive Stage
    • Jinan, China
    • +2 more
    Sep 10, 2023

    Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)

    Recruiting
    • Extensive Small Cell Lung Cancer
    • Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
    • Jinan, Shan Dong, China
      The First Affiliated Hospital of Shandong First Medical Universi
    Nov 6, 2023

    Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

    Recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Jun 6, 2023

    Extensive Stage Small Cell Lung Cancer Trial in Shanghai (HLX10, carboplatin and etoposide, )

    Active, not recruiting
    • Extensive Stage Small Cell Lung Cancer
    • Shanghai, China
    • +5 more
    Sep 28, 2022

    SCLC,Extensive Stage, SLFN11-positive Trial in Worldwide (Niraparib)

    Not yet recruiting
    • SCLC,Extensive Stage
    • SLFN11-positive
    • Angers, France
    • +19 more
    Jan 30, 2023

    Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

    Not yet recruiting
    • Extensive-stage Small-cell Lung Cancer
    • Durvalumab 50 MG/1 ML Intravenous Solution
    • +4 more
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Oct 31, 2022

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    Small Cell Lung Carcinoma Trial in Milano (Cyclic, 5-day calorie restriction, Atezolizumab)

    Not yet recruiting
    • Small Cell Lung Carcinoma
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Jan 19, 2023